针对不可切除的肝细胞癌的新一线免疫疗法:一个活网络的元分析
Jian-Jian Chen1, Zhi-Cheng Jin1, Biao Luo1
1Center of Interventional Radiology & Vascular Surgery, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu, China.
Journal of clinical and translational hepatology
|January 22, 2024
概括
阿特佐利祖马布加贝瓦西祖马布是不可切除的肝细胞癌 (uHCC) 的首选一线治疗方法,其生存益处与其他免疫检查点抑制剂 (ICI) 组合相比较. 治疗选择应平衡疗效,安全性和疾病病因.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 医学瘤学 医学瘤学
- 临床试验 临床试验
背景情况:
- 不切除的肝细胞癌 (uHCC) 治疗已经通过基于免疫检查点抑制剂 (ICI) 的组合疗法取得了进展.
- 建立最佳的一线ICI治疗方案对于改善患者的治疗结果至关重要.
研究的目的:
- 进行网络元分析 (NMA),以评估对HHCC首选一线ICI基础方案的最新证据.
- 为了比较各种一线治疗HHCC的疗效和安全性.
主要方法:
- 一项全面的文献搜索确定了HHCC第一线治疗的第三阶段试验,直到2022年5月.
- 网络元分析 (NMA) 使用随机效应模型评估了整体存活率 (OS) 和无进展存活率 (PFS).
- 根据肝细胞癌的病因,进行了子组分析.
主要成果:
- 12项试验,包括8275名患者,对13种治疗方法进行了比较. 阿特佐利祖马布加贝瓦西祖马布的生存状况与辛蒂利马布加IBI305和卡梅利祖马布加阿帕蒂尼布的生存状况相当.
- 大多数组合疗法与单剂分子向药物 (MTA) 或ICI相比显示出更高的疗效,但不良事件增加.
- 接受ICI组合的乙型肝炎病毒相关的HCC患者与生存优势呈现出正相关性.
结论:
- 阿特佐利祖马布加贝瓦齐祖马布是当前一线HHCC治疗的标准护理,提供与其他ICI组合相似的生存益处.
- 最佳的治疗选择需要考虑疗效,安全性和癌症的特定病因.
- 进一步的研究可能会根据这些因素来改进治疗算法.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
5.2K
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
779
相关概念视频
Tumor Immunotherapy
527
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
